{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:50:52Z","timestamp":1791647452766,"version":"4.3.4"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sub-Saharan Africa (SSA) is undergoing an epidemiological transition with a steady rise in non-communicable diseases. Among these diseases, metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a rapidly increasing public health burden, but is inaccurately documented. We characterized the MAFLD prevalence and identified associated risk factors among adults in SSA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched PubMed\/Medline, Cochrane, Embase, Web of Science, Google Scholar, and African Journals Online for studies looking into the prevalence of and the risk factors for MAFLD in SSA. Studies from 1990 in the English language were included, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for reporting. The quality of the studies was assessed using the Newcastle\u2013Ottawa Scale. A random-effects model was used to estimate the prevalence and the risk factors with 95% confidence intervals (CIs). Meta-regression was used for the subgroup analyses to account for heterogeneity. Stata version 17 software was used for the analysis. This study was registered with PROSPERO (registration no. CRD42024506067).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 538 studies were identified, with 22 included in the analysis. The overall prevalence of MAFLD was 29\u00b721% (95%CI = 22.09\u201336.88, <jats:italic>p<\/jats:italic> &amp;lt; 0.05). Regionally, the results were: West, 34.36%; South, 26.92%; and East, 24.56%. The prevalence of MAFLD among people living with HIV was 13.02%, with diabetes was 37.06%, with hypertension was 36.75%, and with a body mass index above 25 kg\/m<jats:sup>2<\/jats:sup> was 46.05%. The prevalence was higher in women than in men (27.13% <jats:italic>vs<\/jats:italic>. 23.01%), as shown in studies conducted from 2000 onwards compared with those conducted between 2009 and 2019 (30.23% <jats:italic>vs<\/jats:italic>. 28.4%) and in studies with small sample sizes &amp;lt;500 than in studies with large sample sizes &amp;gt;500 (32.42% <jats:italic>vs<\/jats:italic>. 12.17%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>MAFLD is highly prevalent in SSA, with a steady increasing magnitude. The significant risk factors included diabetes, hypertension, obesity, and female sex. This study underscores the emerging need of clinicians in SSA to screen MAFLD among patients at high risk and to instigate tailored care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42024506067.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgstr.2025.1506032","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T06:30:09Z","timestamp":1743489009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and risk factors of metabolic-associated fatty liver disease in sub-Saharan Africa: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"4","author":[{"given":"Emmanuel M.","family":"Sindato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet Dismas","family":"Kajogoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ngajilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwossen Amogne","family":"Degu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Mlawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: A systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05042.x","article-title":"How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences","volume":"22","author":"Amarapurkar","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9359-2","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia","volume":"7","author":"Goh","year":"2013","journal-title":"Hepatol Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101526","DOI":"10.1016\/j.clinre.2020.06.022","article-title":"Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea","volume":"45","author":"Im","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0239393","article-title":"Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019","volume":"15","author":"Wang","year":"2020","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"B11","volume-title":"The Continuing Epidemiological Transition in Sub-Saharan Africa A Workshop Summary-Health Financing in sub-Saharan Africa","year":"2012"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-019-4539-5","article-title":"Diabetes mellitus among patients attending TB clinics in Dar es Salaam: A descriptive cross-sectional study","volume":"19","author":"Munseri","year":"2019","journal-title":"BMC Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-010-9492-y","article-title":"Epidemiological transition and the double burden of disease in Accra, Ghana","volume":"87","author":"Agyei-Mensah","year":"2010","journal-title":"J Urban Heal"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101133","article-title":"Annals of Hepatology Concise reviews A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Hepatol, J Hepatol, Ann Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.10.011","article-title":"MASLD emerging from the fog of fatty liver","volume":"80","author":"Marchesini","year":"2024","journal-title":"J Hepatology. Eur Assoc Study Liver"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"Expert Opinion A new de fi nition for metabolic dysfunction-associated fatty liver disease : An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-21-269","article-title":"Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease","volume":"10","author":"Alharthi","year":"2021","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12876-022-02576-4","article-title":"A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China : a cross \u2212 sectional study","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B19","article-title":"Clinical features and pathogenesis","volume":"2","author":"Basaranoglu","year":"2006","journal-title":"Gastroenterol Hepatol (New York)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.30699\/ijp.2017.25038","article-title":"Clinical manifestations and diagnosis of nonalcoholic fatty liver disease","volume":"12","author":"Khoonsari","year":"2017"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA - J Am Med Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2478\/jomb-2014-0059","article-title":"Pediatric non-alcoholic fatty liver disease","volume":"34","author":"Delvin","year":"2014","journal-title":"J Med Biochem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164051","article-title":"Obesity management in the primary prevention of hepatocellular carcinoma","author":"Heintz","year":"2022"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)30828-2","article-title":"Fatty liver and hyperlipidemia in a cohort of HIV-positive africans on highly active antiretroviral therapy","volume":"101","author":"Lesi","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.1422","article-title":"O RIGINAL A RTICLES Non-alcoholic fatty liver disease (NAFLD) in the Western Cape : A descriptive analysis","volume":"100","author":"Kruger","year":"2010","journal-title":"South Afr Med J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31559-5","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community","volume":"10","author":"Onyekwere","year":"2019","journal-title":"Ann Hepatol"},{"key":"B27","first-page":"2","article-title":"Prevalence of non-alcoholic fatty liver among adults in khartoum- Sudan: epidemiological survey","volume":"9","author":"Bahaaedin","year":"2013","journal-title":"J Am Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2014.01.008","article-title":"Non alcoholic fatty liver disease (NAFLD) in a Sudanese population : What is the prevalence and risk factors","volume":"15","author":"Almobarak","year":"2014","journal-title":"Arab J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2015.06.001","article-title":"Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes : Is metabolic syndrome the culprit","volume":"16","author":"Almobarak","year":"2015","journal-title":"Arab J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0117813","article-title":"Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa","volume":"10","author":"Hoffmann","year":"2015","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2016.24.20.8181","article-title":"Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus","volume":"8688","author":"Olusanya","year":"2016","journal-title":"Pan Afr Med J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2017.06.001","article-title":"The relationship between glycaemic control and non-alcoholic fatty liver disease in Nigerian type 2 diabetic patients","volume":"110","author":"Ishmael","year":"2017","journal-title":"J Natl Med Assoc"},{"key":"B33","article-title":"Prevalence of hepatic steatosis as diagnosed on unenhanced abdominal computed tomography","volume":"95","author":"Karim","year":"2018","journal-title":"East Afr Med J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4314\/ejhs.v28i1.4","article-title":"Non-alcoholic fatty liver disease and associated factors among type 2 diabetic patients in southwest Ethiopia","volume":"28","author":"Zawdie","year":"2018","journal-title":"Ethiop J Health Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.21276\/sjmps.2019.5.1.7","article-title":"Prevalence of non alcoholic fatty liver diseases in general population, khartoum \u2013 Sudan","volume":"4929","author":"Abdalla","year":"2019","journal-title":"Saudi J Med Pharm Sci"},{"key":"B36","first-page":"67","article-title":"Nonalcoholic fatty liver disease among adults attending medical outpatient clinic using ultrasound","volume":"32","author":"Odenigbo","year":"2020","journal-title":"Orient J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2168381","article-title":"Prevalence of metabolic syndrome and nonalcoholic fatty liver disease among premenopausal and postmenopausal women in ho municipality : A cross-sectional study","volume":"2020","author":"Setroame","year":"2020","journal-title":"BioMed Res Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzaa053_114","article-title":"Opportunistic screening for nonalcoholic fatty liver disease (NAFLD) in Ghana: A prospective study","volume":"4","author":"Ssentongo","year":"2020","journal-title":"Curr Dev Nutr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2022-000945","article-title":"Liver steatosis and metabolic associated fatty liver disease among HIV- \u00ad positive and negative adults in urban Zambia","volume":"9","author":"Chihota","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/edm2.v6.6","article-title":"Fatty liver biomarkers and insulin resistance indices in the prediction of non- \u00ad alcoholic fatty liver disease in Ghanaian patients","author":"Bockarie","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4236\/ojgas.2023.1310030","article-title":"Factors associated with hepatic steatosis in black african subjects with chronic viral hepatitis B in c\u00f4te d \u2018 Ivoire","volume":"12","author":"Hatrydt","year":"2023","journal-title":"Open J Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13927","article-title":"Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population","volume":"59","author":"Lajeunesse-trempe","year":"2023","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113741","article-title":"Non-alcoholic fatty liver disease and liver fibrosis in persons with type 2 diabetes mellitus in Ghana : A study of prevalence, severity, and contributing factors using transient elastography","volume":"12","author":"Wiafe","year":"2023","journal-title":"J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/apt.17931","article-title":"Prevalence and risk factors of metabolic dysfunction- \u00ad associated steatotic liver disease in south Central Uganda : A sectional survey","author":"Enriquez","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12876-024-03164-4","article-title":"Non \u2212 alcoholic fatty liver disease in Tanzania : prevalence, determinants, and diagnostic performance of triglycerides \u2212 glucose index and triglycerides \u2212 glucose index \u2013 body mass index compared to the hepatic ultrasound in overweight and obese indivi","volume":"24","author":"Kilonzo","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"B46","article-title":"The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta- analysis bias and confounding newcastle-ottowa scale","author":"Shea","year":""},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2468-1253(21)00275-2","article-title":"Series Non-alcoholic fatty liver disease in sub-Saharan Africa 1 Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa","volume":"1253","author":"Spearman","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101209","DOI":"10.1016\/j.jceh.2023.06.009","article-title":"Prevalence of non-alcoholic fatty liver disease in Iran: A systematic review and meta-analysis","volume":"14","author":"Tabaeian","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30213-2","article-title":"Review Nomenclature and definition of metabolic-associated fatty liver disease : a consensus from the Middle East and north Africa","volume":"1253","author":"Shiha","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non- \u00ad alcoholic fatty liver disease at the global, regional and national levels, 1990 \u2013 2017 : a population- \u00ad based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0191388","article-title":"Steatosis in South African women : How much and why","author":"Naran","year":"2018","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Prevalence, severity, and outcomes in the United States","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-446","article-title":"The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaian women","volume":"6","author":"Kow","year":"2013","journal-title":"BMC Res Notes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/22201009.2011.10872250","article-title":"High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetes clinic","volume":"16","author":"Paruk","year":"2011","journal-title":"JEMDSA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10023-3","article-title":"The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product : a meta \u2212 analysis","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100706","article-title":"Annals of Hepatology Non-alcoholic fatty liver disease prevalence in Latin America : A systematic review and meta-analysis","volume":"27","author":"Ortega","year":"2022","journal-title":"Ann Hepatol"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1506032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T06:30:37Z","timestamp":1743489037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1506032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":56,"alternative-id":["10.3389\/fgstr.2025.1506032"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2025.1506032","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"1506032"}}